Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

被引：0
|
作者：
Jeeyun Lee
Joon Oh Park
Won Seog Kim
Se Hoon Park
Keon Woo Park
Moon Seok Choi
Joon Hyoek Lee
Kwang Cheol Koh
Seung Woon Paik
Byung Chul Yoo
Jaewon Joh
Kihyun Kim
Chul Won Jung
Young Suk Park
Young-Hyuck Im
Won Ki Kang
Mark H. Lee
Keunchil Park
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Division of Gastroenterology, Department of Medicine, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 54卷
关键词：
Doxorubicin; Cisplatin; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 390
页数：5
相关论文
共 50 条
  • [1] Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
    Lee, J
    Park, JO
    Kim, WS
    Park, SH
    Park, KW
    Choi, MS
    Lee, JH
    Koh, KC
    Paik, SW
    Yoo, BC
    Joh, J
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (05) : 385 - 390
  • [2] Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma
    Lee, J. O.
    Lee, K. W.
    Oh, D. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. Y.
    Bang, Y. J.
    ANNALS OF ONCOLOGY, 2009, 20 (08) : 1402 - 1407
  • [3] Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
    Se Hoon Park
    Yuna Lee
    Sang Hoon Han
    So Young Kwon
    Oh Sang Kwon
    Sun Suk Kim
    Ju Hyun Kim
    Yeon Ho Park
    Jeong Nam Lee
    Soo-Mee Bang
    Eun Kyung Cho
    Dong Bok Shin
    Jae Hoon Lee
    BMC Cancer, 6
  • [4] Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma
    Schmid, Irene
    Haeberle, Beate
    Albert, Michael H.
    Corbacioglu, Selim
    Froehlich, Birgit
    Graf, Norbert
    Kammer, Birgit
    Kontny, Udo
    Leuschner, Ivo
    Scheel-Walter, Hans-Gerhard
    Scheurlen, Wolfram
    Werner, Sebastian
    Wiesel, Thomas
    von Schweinitz, Dietrich
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 539 - 544
  • [5] Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
    Dodd, PM
    McCaffrey, JA
    Mazumdar, M
    Scher, H
    Vlamis, V
    Higgins, G
    Herr, H
    Bajorin, DF
    CANCER, 1999, 85 (05) : 1145 - 1150
  • [6] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
    Ruey-Long Hong
    Yun-Long Tseng
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 433 - 438
  • [7] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
    Hong, RL
    Tseng, YL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (05) : 433 - 438
  • [8] A PHASE-2 STUDY OF CISPLATIN IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    OKADA, S
    OKAZAKI, N
    NOSE, H
    SHIMADA, Y
    YOSHIMORI, M
    AOKI, K
    ONCOLOGY, 1993, 50 (01) : 22 - 26
  • [9] A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma
    Yau, T. K.
    Shum, T.
    Lee, A. W. M.
    Yeung, M. W.
    Ng, W. T.
    Chan, L.
    ORAL ONCOLOGY, 2012, 48 (05) : 441 - 444
  • [10] Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary
    Voog, E
    Merrouche, Y
    Trillet-Lenoir, V
    Lasset, C
    Peaud, PY
    Rebattu, P
    Negrier, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (06): : 614 - 616
12345